adenosine monophosphate has been researched along with Diabetic Neuropathies in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Baeeri, M; Dastgheib, M; Gholami, M; Hosseini, A; Karimi, MY; Shetab-Boushehri, SV | 1 |
| Huang, M; Jia, S; Wang, P; Wei, J; Wei, Y | 1 |
| Chang, YS; Cho, YR; Hong, BY; Kim, HW; Kim, MY; Kim, TW; Kim, YS; Lim, JH; Park, CW | 1 |
| Katz, NK; Ryals, JM; Wright, DE | 1 |
| Kumar, A; Yerra, VG | 1 |
| MEDURI, D | 1 |
1 review(s) available for adenosine monophosphate and Diabetic Neuropathies
| Article | Year |
|---|---|
Is metformin a possible treatment for diabetic neuropathy?
Topics: Adenosine Monophosphate; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Humans; Hypoglycemic Agents; Metformin; Neuroprotective Agents; Pain; Protein Kinases; Vitamin B 12 | 2022 |
5 other study(ies) available for adenosine monophosphate and Diabetic Neuropathies
| Article | Year |
|---|---|
Rolipram and pentoxifylline combination ameliorates experimental diabetic neuropathy through inhibition of oxidative stress and inflammatory pathways in the dorsal root ganglion neurons.
Topics: Adenosine Monophosphate; Animals; Biomarkers; Cyclooxygenase 2; Diabetic Neuropathies; Ganglia, Spinal; Neurons; NF-kappa B; Oxidative Stress; Pentoxifylline; Phosphodiesterase 4 Inhibitors; Rats; Reactive Oxygen Species; Rolipram; Sulfhydryl Compounds; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2022 |
Therapeutic effects of fenofibrate on diabetic peripheral neuropathy by improving endothelial and neural survival in db/db mice.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adenosine Monophosphate; AMP-Activated Protein Kinases; Animals; Blood Glucose; Body Weight; Cell Survival; Deoxyguanosine; Diabetic Neuropathies; Disease Models, Animal; Endothelial Cells; Fenofibrate; Fibrosis; Glycated Hemoglobin; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lipids; Mice; Neural Conduction; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Platelet Endothelial Cell Adhesion Molecule-1; PPAR alpha; Receptors, Vascular Endothelial Growth Factor; Schwann Cells; Sciatic Nerve; Sciatic Neuropathy; Transcription Factors; Transforming Growth Factor beta1 | 2014 |
Central or peripheral delivery of an adenosine A1 receptor agonist improves mechanical allodynia in a mouse model of painful diabetic neuropathy.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine Monophosphate; Analgesics, Non-Narcotic; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Foot; Ganglia, Spinal; Hindlimb; Hydrolysis; Hyperalgesia; Injections, Spinal; Male; Mice; Neurons; Receptor, Adenosine A1; Spinal Cord; Touch | 2015 |
Adenosine Monophosphate-Activated Protein Kinase Abates Hyperglycaemia-Induced Neuronal Injury in Experimental Models of Diabetic Neuropathy: Effects on Mitochondrial Biogenesis, Autophagy and Neuroinflammation.
Topics: Adenosine Monophosphate; Animals; Autophagy; Central Nervous System Diseases; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Hyperglycemia; Male; Mitochondria; Models, Theoretical; Organelle Biogenesis; Oxidative Stress; Rats, Sprague-Dawley | 2017 |
[ASSOCIATION OF 2 ANTIDIABETIC DRUGS FOR ORAL USE WITH AMP, THIAMINE AND VITAMIN B 12 IN THE TREATMENT OF DIABETIC POLYNEURITIS].
Topics: Adenine Nucleotides; Adenosine Monophosphate; Blood Proteins; Cholesterol; Diabetic Neuropathies; Glycoproteins; Glycosuria; Humans; Hypoglycemic Agents; Lipids; Lipoproteins; Neuritis; Pyruvates; Thiamine; Vitamin B 12 | 1964 |